Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 2096-2103, April 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steck, P. A.
Right arrow Articles by Yung, W. K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steck, P. A.
Right arrow Articles by Yung, W. K. A.

Altered Expression and Distribution of Heparan Sulfate Proteoglycans in Human Gliomas1

Peter A. Steck2, Richard P. Moser, Janet M. Bruner, Lin Liang, Allon N. Freidman, Te-Long Hwang and W. K. Alfred Yung

Departments of Neuro-Oncology [P. A. S., L. L., A. N. F., T. L. H., W. K. A. Y.], Head and Neck Surgery [R. P. M.], and Pathology [J. M. B.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

The expression of heparan sulfate proteoglycans (HSPGs) by human glioma cells was examined by biochemical and immunological methods in vitro and in vivo. Chondroitin sulfate was shown to represent the major [3H]glucosamine-labeled glycosaminoglycan synthesized by cultured normal brain cells. However, high-grade glioma-derived cells were shown to express significantly increased quantities of hyaluronic acid and heparan sulfate and approximately equal amounts of chondroitin sulfate compared with normal glial cells. To investigate further the differential expression of HSPGs, proteoglycans were isolated from glioma cells and were used as an immunogen to generate monoclonal antibodies (MAbs). One of these MAbs, 39H (an IgM), was shown to bind more to high-grade glioma-derived cells then to low-grade glioma or normal brain cells in vitro. MAb 39H was also observed to bind to isolated HSPGs but not to heparan sulfate glycosaminoglycan chains or trypsin-treated cells. Immunofluorescence staining of the cultured high-grade glioma cells revealed an intense diffuse cell surface staining pattern over the entire cell and also isolated footpads. In contrast, the low-grade tumor or normal glial cells showed a distinctive punctated staining. A similar differential staining of MAb 39H was most prominent between tissue sections of glioblastoma multiforme and anaplastic astrocytomas versus low-grade astrocytomas and normal brain. The low grade gliomas exhibited a weak punctated staining, whereas the high-grade gliomas showed significantly more intense staining, particularly along the apical regions of the cells. These results suggest that altered expression of HSPGs may be related to the malignant transformation or growth potential of glial-derived cells.

1 Supported by grants from the J. S. Dunn Research Foundation and the Preuss Foundation, USPHS Grant RO1 CA42729 from the National Cancer Institute, and NIH Grant RR5511-23.

2 To whom requests for reprints should be addressed.

Received 7/28/88. Revised 11/28/88. Accepted 1/10/89.




This article has been cited by other articles:


Home page
Neuro OncolHome page
S. F. Hussain, D. Yang, D. Suki, K. Aldape, E. Grimm, and A. B. Heimberger
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses
Neuro-oncol, July 1, 2006; 8(3): 261 - 279.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Su, K. Meyer, C. D. Nandini, D. Qiao, S. Salamat, and A. Friedl
Glypican-1 Is Frequently Overexpressed in Human Gliomas and Enhances FGF-2 Signaling in Glioma Cells
Am. J. Pathol., June 1, 2006; 168(6): 2014 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Yamamoto, Y. Yoshida, M. Aoyagi, K. Ohno, K. Hirakawa, and H. Hamada
Reduced Transduction Efficiency of Adenoviral Vectors Expressing Human p53 Gene by Repeated Transduction into Glioma Cells in Vitro
Clin. Cancer Res., March 1, 2002; 8(3): 913 - 921.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
L. B. Thomas and D. A. Steindler
Review : Glial Boundaries and Scars: Programs for Normal Development and Wound Healing in the Brain
Neuroscientist, May 1, 1995; 1(3): 142 - 154.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.